Milwaukee, WI, United States of America

Promentis Pharmaceuticals, Inc.


USPTO Granted Patents = 9

% Expired Patents = 33.3



Trademarks = 1

Forward Citations = 39

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Daniel Lawton (7 out of 7 patents)

silverMedal Michael Neary (7 out of 7 patents)

bronzeMedal James Nieman (6 out of 15 patents)

4.  Steven Paul Tanis (5 out of 42 patents)

5.  Garry Robert Smith (4 out of 33 patents)

6.  Mark Allan Wolf (2 out of 10 patents)

7.  Keith Douglas Barnes (2 out of 5 patents)

8.  Edward M Johnson, Ii (1 out of 1 patent)


9 patents:

Company Overview
Promentis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for neuropsychiatric and neurologic disorders. Their pipeline includes novel small molecule drugs targeting specific brain receptors to treat conditions such as schizophrenia, Tourette syndrome, and substance use disorders.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

9 Patents

#105 in Milwaukee, WI

#719 in Wisconsin

#32,588 in US

Milwaukee, WI (US)
Milwaukee, WI, United States of America
Forward Citations = 39

8 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Promentis Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/promentis-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…